17min chapter

The Trip Report cover image

Ep #30 Nick Gillespie: Reflection on the FDA’s Rejection of MDMA Assisted Therapy

The Trip Report

CHAPTER

The FDA and MDMA: Navigating Therapy Rejections

This chapter explores the FDA's recent rejection of MDMA-assisted therapy for PTSD, highlighting the complexities and frustrations that surround such regulatory decisions. It critiques the agency's role in upholding existing power structures and reflects on the evolving relationship between personal health choices and pharmaceutical approval processes. The discussion underscores the need for a shift to more individualized healthcare approaches while contemplating the implications of these decisions on public trust and access to transformative treatments.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode